ArticleJMA journal2026
Integrating Behavioral Science-Based Interventions in the Treatment of Refractory Atopic Dermatitis and Associated Behavioral Problems.
Article in JMA journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This report highlights the successful integration of behavioral science-based interventions in the treatment of an 8-year-old girl with atopic dermatitis (AD) and behavioral problems, including tantrums. The patient, who had a history of poorly managed AD, presented with worsened eczema and sleep disturbances, in addition to increased tantrums, scratching, and reluctance to attend school. She was admitted for inpatient treatment, which included standard AD management and multidisciplinary care, focusing on proper skin care, diet, and lifestyle changes. Despite relief of her eczema, her problematic behaviors persisted, which worsened her condition. To address this, behavioral interventions were implemented. Anger management techniques were introduced, whereby the patient assessed her anger levels and used relaxation methods. She was taught alternative behaviors to manage the itching, such as applying topical treatments or interacting with her favorite stuffed animal. Her parents also received guidance on managing her behavior. Over her three-month hospitalization, her tantrums and problematic behaviors resolved, and her AD went into remission. Post-discharge, her eczema remained well controlled, and her behavior improved, with no recurrence of tantrums or other issues. This case illustrates the importance of combining pharmacological treatments with behavioral interventions in managing AD and associated psychosocial challenges. Behavioral science-based approaches can play a crucial role in alleviating behavioral issues linked to AD, such as anger and scratching, which can further exacerbate the condition. In this case, behavioral therapy effectively alleviated the patient's behavior problems and improved eczema control, underscoring the need for clinicians to be equipped to address both the physical and behavioral aspects of AD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.